o

Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

Preventing Chronic Disease: Public Health Research, Practice and Policy

View Current Issue
Issue Archive
Archivo de números en español








Emerging Infectious Diseases Journal
MMWR


 Home 

Volume 7: No. 3, May 2010

ORIGINAL RESEARCH
Prevalence, Awareness, Treatment, and Control of High LDL Cholesterol in New York City, 2004

ATP III Risk Group % of NYC Adults
Low
Normal LDL cholesterol 59.5
High LDL cholesterol/aware 4.3
High LDL cholesterol/unaware 1.0
Moderate
Normal LDL cholesterol 7.2
High LDL cholesterol/aware 2.8
High LDL cholesterol/unaware 0.5
Moderately high
Normal LDL cholesterol 2.6
High LDL cholesterol/aware 2.5
High LDL cholesterol/unaware 1.5
High
Normal LDL cholesterol 2.8
High LDL cholesterol/aware 10.1
High LDL cholesterol/unaware 5.0

Figure. Age-standardized prevalence of high LDL cholesterol among NYC adults by ATP-III risk category (5,14), New York City Health and Nutrition Examination Survey, 2004. High LDL cholesterol defined as currently taking cholesterol-lowering medications or having LDL cholesterol levels at or greater than the ATP-III risk-specific thresholds recommended for initiation of drug therapy: ≥100 mg/dL for the high-risk group, ≥130 mg/dL for the moderately high-risk group, ≥160 mg/dL for the moderate-risk group, and ≥190 mg/dL for the low-risk group.

Return to article

 




 



The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.


 Home 

Privacy Policy | Accessibility

CDC Home | Search | Health Topics A-Z

This page last reviewed March 22, 2013

Centers for Disease Control and Prevention
National Center for Chronic Disease Prevention and Health Promotion
 HHS logoUnited States Department of
Health and Human Services